Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors

Leukemia inhibitory factor; Safety; Solid tumors

Bibliographic Details
Authors:	Borazanci, Erkut, Schram, A. M., Garralda Cabanas, Elena, Braña Garcia, Irene, Vieito Villar, Maria, Spreafico, A., Seoane Suarez, Joan, Tabernero Caturla, Josep
Format:	article
Status:	Published version
Publication Date:	2022
Country:	España
Institution:	Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:	Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:	oai:recercat.cat:11351/8316
Online Access:	https://hdl.handle.net/11351/8316 http://hdl.handle.net/11351/8316
Access Level:	Open access
Keyword:	Càncer Anticossos monoclonals Posologia CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized DISEASES::Neoplasms PHENOMENA AND PROCESSES::Cell Physiological Phenomena::Cellular Microenvironment::Tumor Microenvironment COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados ENFERMEDADES::neoplasias FENÓMENOS Y PROCESOS::fenómenos fisiológicos celulares::microambiente celular::microambiente tumoral

Description
Summary:	Leukemia inhibitory factor; Safety; Solid tumors